Search Results

There are 1920 results for: content related to: Intranasal Zolmitriptan for the Treatment of Acute Migraine

  1. You have free access to this content
    Zolmitriptan for acute migraine attacks in adults

    Intervention Review

    The Cochrane Library

    Sarah Bird, Sheena Derry and R Andrew Moore

    Published Online : 21 MAY 2014, DOI: 10.1002/14651858.CD008616.pub2

  2. You have free access to this content
    Triptans for acute cluster headache

    Intervention Review

    The Cochrane Library

    Simon Law, Sheena Derry and R Andrew Moore

    Published Online : 17 JUL 2013, DOI: 10.1002/14651858.CD008042.pub3

  3. Meta-Analysis of the Efficacy and Safety of Zolmitriptan in the Acute Treatment of Migraine

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 2, February 2008, Pages: 236–247, Li-Chia Chen and Darren M. Ashcroft

    Version of Record online : 27 DEC 2007, DOI: 10.1111/j.1526-4610.2007.01007.x

  4. Effects of the antimigraine compound zolmitriptan (‘Zomig’) on psychomotor performance alone and in combination with diazepam in healthy volunteers

    Cephalalgia

    Volume 18, Issue 7, September 1998, Pages: 468–475, R Dixon, AM Hughes, K Nairn, M Sellers, JV Kemp and RA Yates

    Version of Record online : 7 JUL 2008, DOI: 10.1111/j.1468-2982.1998.1807468.x

  5. Determination of zolmitriptan enantiomers in rat liver microsomes by chiral high performance liquid chromatography with fluorescence detection

    Biomedical Chromatography

    Volume 19, Issue 3, April 2005, Pages: 191–195, Lushan Yu, Tongwei Yao, Shaoqing Ni and Su Zeng

    Version of Record online : 13 OCT 2004, DOI: 10.1002/bmc.433

  6. Triptans attenuate circadian responses to light

    European Journal of Neuroscience

    Volume 42, Issue 7, October 2015, Pages: 2489–2495, Priyoneel Basu, Naomi Ie, Adrienne L. Wensel, Joelle D. Baskerville, Victoria M. Smith and Michael C. Antle

    Version of Record online : 25 AUG 2015, DOI: 10.1111/ejn.13032

  7. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design

    Cephalalgia

    Volume 20, Issue 1, February 2000, Pages: 30–38, G Geraud, J Olesen, V Pfaffenrath, P Tfelt-Hansen, R Zupping, H-c Diener, R Sweet, On Behalf Of and The Study Group

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1468-2982.2000.00004.x

  8. Annual Meeting Program Abstracts

    Headache: The Journal of Head and Face Pain

    Volume 44, Issue 5, June 2004, Pages: 457–536,

    Version of Record online : 1 JUN 2004, DOI: 10.1111/j.1526-4610.2004.t01-1-.x

  9. Preliminary Studies of the Pharmacokinetics and Tolerability of Zolmitriptan Nasal Spray in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 42, Issue 11, November 2002, Pages: 1237–1243, Dr. Roger Yates, Mr. Kevin Nairn, Ms. Ruth Dixon and Ms. Emma Seaber

    Version of Record online : 8 MAR 2013, DOI: 10.1177/009127002762491325

  10. The Long-term Tolerability and Efficacy of Oral Zolmitriptan (Zomig, 31X90) in the Acute Treatment of Migraine. An International Study

    Headache: The Journal of Head and Face Pain

    Volume 38, Issue 3, March 1998, Pages: 173–183, Dr. Roger K. Cady and The International 311C90 Long-term Study Group

    Version of Record online : 5 JUN 2003, DOI: 10.1046/j.1526-4610.1998.3803173.x

  11. Zolmitriptan Intranasal: A Review of the Pharmacokinetics and Clinical Efficacy

    Headache: The Journal of Head and Face Pain

    Volume 46, Issue 1, January 2006, Pages: 138–149, Peter J. Goadsby and Roger Yates

    Version of Record online : 10 JAN 2006, DOI: 10.1111/j.1526-4610.2006.00301.x

  12. Pharmacokinetics, Dose Proportionality, and Tolerability of Single and Repeat Doses of a Nasal Spray Formulation of Zolmitriptan in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 42, Issue 11, November 2002, Pages: 1244–1250, Dr. Roger Yates, Kevin Nairn, Ruth Dixon, J. V. Kemp and A. L. Dane

    Version of Record online : 8 MAR 2013, DOI: 10.1177/009127002762491334

  13. A Comparative Trial of Zolmitriptan and Sumatriptan for the Acute Oral Treatment of Migraine

    Headache: The Journal of Head and Face Pain

    Volume 40, Issue 2, February 2000, Pages: 119–128, R. Michael Gallagher, George Dennish, Egilius L.H. Spierings and Rohini Chitra

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1526-4610.2000.00017.x

  14. Efficacy and Tolerability of Oral Zolmitriptan in Menstrually Associated Migraine: A Randomized, Prospective, Parallel-Group, Double-blind, Placebo-Controlled Study

    Headache: The Journal of Head and Face Pain

    Volume 44, Issue 2, February 2004, Pages: 120–130, Elizabeth Loder, Stephen D. Silberstein, Susan Abu-Shakra, Loretta Mueller and Timothy Smith

    Version of Record online : 3 FEB 2004, DOI: 10.1111/j.1526-4610.2004.04027.x

  15. Zolmitriptan oxalate and zolmitriptan camphorsulfonate: the first structural study of salt complexes of the antimigraine drug zolmitriptan

    Acta Crystallographica Section C

    Volume 69, Issue 10, October 2013, Pages: 1186–1191, Balasubramanian Sridhar, Krishnan Ravikumar and Venkatasubramanian Hariharakrishnan

    DOI: 10.1107/S0108270113024323

  16. You have free access to this content
    The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90)

    British Journal of Clinical Pharmacology

    Volume 44, Issue 6, December 1997, Pages: 595–599, Richard W. Peck, Emma J. Seaber, Ruth Dixon*, Catherine G. Gillotin†, Barry C. Weatherley, Gary Layton** and John Posner‡

    Version of Record online : 2 OCT 2003, DOI: 10.1046/j.1365-2125.1997.t01-1-00632.x

  17. Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine—Results From Phase 1 of the REALIZE Study

    Headache: The Journal of Head and Face Pain

    Volume 45, Issue 1, January 2005, Pages: 7–16, Marek Gawel, Jürgen Aschoff, Arne May, Bruce R. Charlesworth and REALIZE Study Team

    Version of Record online : 22 DEC 2004, DOI: 10.1111/j.1526-4610.2005.05004.x

  18. Pharmacokinetics and Pharmacodynamics of Zolmitriptan in Patients with Mild to Moderate Hypertension: A Double-Blind, Placebo-Controlled Study

    The Journal of Clinical Pharmacology

    Volume 38, Issue 8, August 1998, Pages: 685–693, Dr. Deborah A. Smith, Dr. Elena W. Cleary, Ms. Stephanie Watkins, Mr. Cameron S. Huffman, Ms. Stacy C. Dilzer and Dr. Kenneth C. Lasseter

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1998.tb04807.x

  19. Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin

    European Journal of Pain

    Volume 19, Issue 7, August 2015, Pages: 966–972, K. Döring, C. Best, F. Birklein and H.H. Krämer

    Version of Record online : 13 NOV 2014, DOI: 10.1002/ejp.622

  20. The therapeutic profile of zolmitriptan in clinical practice

    International Journal of Clinical Practice

    Volume 58, Issue 8, August 2004, Pages: 795–800, H.C. Diener, 1 S. Evers and 2 A. Gendolla 1

    Version of Record online : 27 AUG 2004, DOI: 10.1111/j.1368-5031.2004.00272.x